Achyut Healthcare: Akshit Raycha Boosts Stake to 8.95% Via Preferential Allotment

Akshit Mahendra Raycha has acquired 8,00,000 equity shares in Achyut Healthcare Limited through a preferential allotment, boosting his total stake to 8.95% (2,15,90,000 shares). This transaction, completed on March 23, 2026, raised the company's total equity share capital from ₹23.56 crore to ₹24.14 crore. Previously, Raycha held 8.61% of the company's voting capital.

Significance of the Stake Increase

An increased stake by a key investor like Raycha typically signals growing confidence in a company's future prospects. For Achyut Healthcare, the preferential allotment also serves as a method to raise essential capital, strengthening its financial resources and increasing Raycha's voting power.

About Achyut Healthcare

Achyut Healthcare, based in Ahmedabad, India, manufactures and sells pharmaceutical formulations, active pharmaceutical ingredients (APIs), and medical devices. Incorporated in 1996, the company has a history of raising funds through various methods, including preferential allotments and Qualified Institutional Placements (QIPs).

The company recently migrated from the BSE SME platform to the BSE Main Board on January 2, 2026, seeking greater market visibility. Before this latest allotment, Akshit M. Raycha HUF, a promoter group entity, had been acquiring shares via open market purchases.

Transaction Impact

The direct impact of this transaction includes a modest increase in Akshit Mahendra Raycha's influence and voting power within Achyut Healthcare. The expansion of the company's equity share capital may alter key financial ratios and per-share metrics, while the raised capital itself will bolster the company's financial structure.

Areas of Concern

Despite the stake increase, Achyut Healthcare has faced significant margin pressures and volatile profit margins. The company recently reported a substantial drop in its quarterly net profit.

Additionally, Achyut Healthcare has a history of high average debtor days, standing at around 160 days, and a low return on equity (ROE) of 1.95% over the past three years.

Competitive Landscape

Achyut Healthcare operates within the competitive Indian Pharmaceuticals and Healthcare sector. Key peers include Aster DM Healthcare Ltd, Shalby Ltd, and Mono Pharmacare Ltd, all navigating similar market dynamics and regulatory environments.

Looking Ahead

Investors will be watching how Achyut Healthcare deploys the newly raised capital. Key metrics to track include upcoming financial results for signs of margin improvement and profit growth, any further stake movements by significant shareholders, and the company's ability to manage its debtor days and improve its return on equity.